Predictors of sexual impairment at 6months after a manic episode: A post-hoc analysis of the MANACOR study

L. Al Chaal; Alberto Aedo; María Reinares; Iría Grande; Cristina M. González; Gerard Anmella; Caterina del Mar Bonnín; María Mur; Cristina Sáez; E. Nieto; Ángel L. Montejo; Eduard Vieta; Andréa Murru

doi:10.1016/j.euroneuro.2018.11.589

Related publications

Article2015

Predictors of functional outcome after a manic episode

Caterina del Mar Bonnín, María Reinares, Diego Hidalgo‐Mazzei, Juan Undurraga, María Mur, Cristina Sáez, E. Nieto, Gustavo Vázquez, Vicent Balanzá‐Martínez, Rafael Tabarés‐Seisdedos, Eduard Vieta

Article2015

The Real World Costs of Asenapine in Manic Episodes in the Manacor Study

I. Forcada, Iría Grande, Diego Hidalgo‐Mazzei, E. Nieto, Cristina Sáez, María Mur, Eduard Vieta

Article2015

The real world cost and health resource utilization associated to manic episodes: The MANACOR study

Diego Hidalgo‐Mazzei, Juan Undurraga, María Reinares, Caterina del Mar Bonnín, Cristina Sáez, María Mur, E. Nieto, Eduard Vieta

Article2015

Asenapine prescribing patterns in the treatment of manic in- and outpatients: Results from the MANACOR study

Iría Grande, Diego Hidalgo‐Mazzei, E. Nieto, María Mur, Cristina Sáez, I. Forcada, Eduard Vieta

Article2004

Continuum of renoprotection with Losartan at all stages of type 2 diabetic nephropathy: A post hoc analysis of the RENAAL trial results: A post hoc analysis of the RENAAL trial results

Giuseppe Remuzzi, P. Ruggenenti, Annalisa Perna, Borislav D. Dimitrov, Darcy A. Hille, S. Shahinfar, George W. Carides, Barry M. Brenner, Dick de Zeeuw

Predictors of sexual impairment at 6months after a manic episode: A post-hoc analysis of the MANACOR study

Discussion(0)

Related publications

Predictors of functional outcome after a manic episode

The Real World Costs of Asenapine in Manic Episodes in the Manacor Study

The real world cost and health resource utilization associated to manic episodes: The MANACOR study

Asenapine prescribing patterns in the treatment of manic in- and outpatients: Results from the MANACOR study

Continuum of renoprotection with Losartan at all stages of type 2 diabetic nephropathy: A post hoc analysis of the RENAAL trial results: A post hoc analysis of the RENAAL trial results